Amazon & Co. venture finally has a name: Haven

The name was unveiled on Wednesday, along with a website, havenhealthcare.com, and a letter from CEO Atul Gawande.

By John Tozzi | March 06, 2019 at 05:41 PM

Haven was formed because its founding companies “have been frustrated by the quality, service, and high costs that their employees and families have experienced in the U.S. health system,” Gawande said.

The mysterious new health-care venture announced by Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. will be called Haven, the firm announced Wednesday.

Haven also unveiled a website, havenhealthcare.com, and a letter from Chief Executive Officer Atul Gawande, the surgeon, Harvard professor and writer chosen to lead the venture last June.

Related: Where do benefits brokers fit in Amazon's new health care venture?

Haven wants to improve access to primary care, simplify insurance and make prescription drugs more affordable, according to the website. It will initially serve 1.2 million employees of Amazon, Berkshire and JPMorgan, though it later plans “to share our innovations and solutions to help others.”

Haven was formed because its founding companies “have been frustrated by the quality, service, and high costs that their employees and families have experienced in the U.S. health system,” Gawande said in a letter posted on the website.

Excitement, fear

The website is the most detailed information yet about the year-old, Boston-based venture that has generated excitement in the health-care industry even before details of its plans were made public. It has also raised fears among health insurers, drugmakers and other parts of the industry that the giant companies backing Haven would use their collective power to disrupt established players.

Gawande wrote that Haven “will be an advocate for the patient and an ally to anyone” who wants to improve patient care and costs. The company will “create new solutions and work to change systems, technologies, contracts, policy, and whatever else is in the way of better care,” he wrote.

Last month, Berkshire CEO Warren Buffett praised Gawande as a “terrific fellow,” saying that the venture's goals will be to stop the extreme rise in medical costs and hopefully find a better system for employees. Buffett's business partner, Charles Munger, said in February that it's probably one of the hardest tasks on Berkshire's agenda.

In addition to Gawande, board members of the new venture include Todd Combs, portfolio manager and investment officer at Berkshire, JPMorgan Chief Executive Officer Jamie Dimon, and Beth Galetti, senior vice president at Amazon.

The companies have characterized the venture as a long-term effort that would be free from profit-making incentives and constraints. Haven will reinvest any surplus into its work, according to the website.

The venture has recently been entangled in a legal conflict with UnitedHealth Group Inc.'s Optum unit. Optum sued a former employee, David William Smith, to enforce a noncompete agreement after he was hired by Haven. A federal judge in Massachusetts last month denied Optum's motion for a temporary restraining order to keep Smith from starting work and sent the case to arbitration.

Read more: 

Copyright 2019 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

By Lynn Cavanaugh | January 17, 2025

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, including Pfizer, Novo Nordisk and GlaxoSmithKline.

Ozempic among 15 drugs selected for Medicare drug price talks, Round 2, with Big Pharma

By Allison Bell | January 17, 2025

The company uses public data sets, not secret information, to create out-of-network reimbursement recommendations, according to a new court filing.

MultiPlan responds to lawsuits, says providers want to increase health care prices

By Allison Bell | January 17, 2025

At one large self-funded plan, provider shortages pushed more than 37% of the patients to get their behavioral health care out-of-network.

Employers still skimp on mental health benefits, regulators say
AI in Human Resources: A Strategic Path to Enhanced Efficiency and Engagement link

White Paper

Sponsored by SwellSpace

It’s no secret, Artificial Intelligence (AI) is a transformational force. And it’s already reshaping HR. Explore the ways AI is revolutionizing HR and practical strategies to make your team more strategic and engaging.

A Guide to Transformative Trends Shaping the Employee Benefits Landscape link

Report

Sponsored by ArmadaCare

Are brokers prepared for what’s next? See the 5 hot benefits trends shaping 2025 in this report.

AI-Powered Growth: How Brokers Are Using AI To Increase Profits, Boost Client Satisfaction, and Save Time link

White Paper

Sponsored by SwellSpace

AI isn’t just poised to reshape workflows for benefit brokers - it already is. This paper explores why AI is a force multiplier for benefits advisors, and how it can increase your profits while enabling more personalized outcomes for clients.